Shoppers Drug Mart Corp (SC.TO) Buy, Sell or…

Shoppers Drug Mart Corp (SC.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

0.00

-0.00 (0.00%)

55 watching

BUY

Off about 8.5% and down about 1% over the last year. 1.2% yield. The premier drug company in Canada. If you want pharmaceuticals, this is what you should buy. Good price.

TOP PICK

Has growth and is relatively safe. Pulled back on concerns of Bill 102, but risks have been disseminated so it will mean nothing or a penny or two of earnings.

TOP PICK

Pays 1.17%. The largest pharma presence in Canada. Have done a lot of refurbishing of their stores. A good defensive play. Has had a good correction.

BUY

A core stock. Good performance. Should grow at 15/25% per year in earnings and cash flow.

BUY

In a defensive part of the market. In general, drug stores and the like should do well if the market is slowing down. Prefers Alimentation Couche-Tard (ATD.B-T) but this one should do well.

TOP PICK

A low risk way to play the ageing baby boomers, drug stores are the way the go. A well-run company. The high multiple can be justified because they will continue to execute extremely well.

DON'T BUY

Ontario government is passing Bill 102 which will give generic drugs some leverage. This won't slow their growth although it will affect their earnings. An incredibly expensive stock.

TOP PICK

The P/E multiple on forward earnings is about 17 which is as cheap as it has been for quite a while. Looking for 20% growth. Lots of store rollout still. Down because the Ontario government is looking into the treatment of generic drugs.

DON'T BUY

This one is always expensive to him. Great company with great fundamentals but is not a mis-priced asset. His model price is $39.50 which is a negative 10% differential.

BUY

Probably have six to eight years of double-digit earnings growth in front of it.

BUY ON WEAKNESS

Keeping a close eye on this one. Part of it is in the consumer discretionary area which she is a little bit cautious on. A great company. Good square footage growth. Would like to buy it at $40.

BUY

Continue to execute well. Demographics look wonderful. Continuing to expand. Continue to raise their dividends.

HOLD

Likes it below $40 it's half way to his target of $50. So it's a hold right now. A really solid company.

TOP PICK

ROE growth will likely drive the stock to new levels. This should weather the coming correction. (April May timeframe)

DON'T BUY

A great company, but fully valued at this price.

Showing 301 to 315 of 452 entries

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Shoppers Drug Mart Corp (SC.TO)